-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$19.5021.34% Upside
NOV Inc. Frequently Asked Questions
-
What analysts cover NOV Inc.?
NOV Inc. has been rated by research analysts at Morgan Stanley, Barclays, Susquehanna, Goldman Sachs, Evercore ISI, Cowen & Co. in the past 90 days.